Croda International's (CRDA) Buy Rating Reaffirmed at Berenberg Bank

Croda International (LON:CRDA - Get Free Report)'s stock had its "buy" rating reiterated by research analysts at Berenberg Bank in a research report issued on Thursday, MarketBeat.com reports. They currently have a GBX 3,800 ($50.63) target price on the stock. Berenberg Bank's price objective would indicate a potential upside of 28.77% from the stock's current price.

Croda International Trading Down 2.0 %

Croda International stock traded down GBX 61.01 ($0.81) during midday trading on Thursday, hitting GBX 2,950.99 ($39.32). 933,647 shares of the stock were exchanged, compared to its average volume of 1,598,344. The stock has a market capitalization of £4.13 billion, a PE ratio of 25.36, a P/E/G ratio of 1.40 and a beta of 0.74. The company has a fifty day simple moving average of GBX 2,949.34 and a two-hundred day simple moving average of GBX 3,268.92. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. Croda International has a 52 week low of GBX 2,551 ($33.99) and a 52 week high of GBX 4,932 ($65.72).

Croda International (LON:CRDA - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.90) earnings per share (EPS) for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. Equities research analysts anticipate that Croda International will post 181.8307268 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Ian Bull purchased 400 shares of the business's stock in a transaction dated Tuesday, February 25th. The shares were bought at an average cost of GBX 3,240 ($43.17) per share, for a total transaction of £12,960 ($17,268.49). Also, insider Tom Brophy sold 380 shares of the stock in a transaction dated Monday, April 7th. The stock was sold at an average price of GBX 2,643 ($35.22), for a total value of £10,043.40 ($13,382.28). In the last three months, insiders have purchased 570 shares of company stock worth $1,787,575. Company insiders own 0.93% of the company's stock.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.